Skip to main content

News

Histopathologic image illustrating well differentiated squamous cell carcinoma in the excisional biopsy specimen.

Combination immunotherapy before surgery may increase survival in people with head and neck cancer

Robert Ferris, MD, PhD, and colleagues report in Cancer Cell that head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy drug. Read more
A group of people with their hands stacked in a team-like gesture.

MaTRIC streamlines project management, resources to boost research productivity

MaTRIC is an initiative providing research project management services and resources to enhance population science research at UNC Lineberger. Read more
A microscope slide being placed under a microscope

Partnership brings together scientists, middle schoolers to explore cancer research

The Boys & Girls Club of Durham and Orange Counties partnered with UNC Lineberger to bring predoctoral students, postdoctoral fellows and faculty members to present lay language scientific talks. Read more
Headshot of Melissa Troester.

Troester elected chair of the AACR Populations Sciences Working Group

Melissa Troester, PhD, MPH, will serve as chair-elect and will assume the role of chair for the 2026-2028 term at the 2026 AACR Annual Meeting. Read more
A person wearing head-to-toe medical protective garments at a hooded work station in the Advanced Cellular Therapeutics Facility. They are pipetting into a container.

UNC Lineberger’s Advanced Cellular Therapeutics Facility earns accreditation

The Foundation for the Accreditation of Cellular Therapy awarded accreditation without any deficiency citations to UNC Lineberger’s Advanced Cellular Therapeutics Facility. Read more
Human colon cancer cells with the cell nuclei stained red and the protein E-cadherin stained green. E-cadherin is a cell adhesion molecule and its loss signals a process known as the epithelial-mesenchymal transition in which cells acquire the ability to migrate and become invasive.

Immunotherapy and targeted therapy combination proves effective against metastatic colorectal cancer

UNC Lineberger researchers have demonstrated that combining two immunotherapy drugs with a targeted therapy drug proved effective in treating the most common form of metastatic colorectal cancer. Read more
More
News

Events